Lymphedema pp 681-691 | Cite as

Future Prospects in Lymphatic Reconstructive Surgery

  • Chad M. Teven
  • David W. ChangEmail author


Lymphedema is increasingly recognized as a cause of significant morbidity in those who are affected. While lymphedema can present as a result of many etiologies, in the United States, it is most commonly caused by cancer treatment. Treatment for lymphedema has made progress in recent years due to an improved understanding of the lymphatic system and lymphedema pathophysiology as well as advances in imaging, surgical equipment, and other technologies. However, many limitations still exist with respect to the current treatment approaches and a cure for lymphedema has yet to be found. Moving forward, prevention strategies as well as options to reconstruct and regenerate the lymphatic system will come into focus. This chapter will highlight the current options, emerging technologies, and future prospects in lymphatic surgery.

Highlighted References

  1. 1.
    Mehrara BJ, Zampell JC, Suami H, Chang DW. Surgical management of lymphedema: past, present, and future. Lymphat Res Biol. 2011;9(3):159–67.CrossRefPubMedGoogle Scholar
  2. 2.
    Chang DW, Suami H, Skoracki R. A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema. Plast Reconstr Surg. 2013;132(5):1305–14.CrossRefPubMedGoogle Scholar
  3. 3.
    Raju A, Chang DW. Vascularized lymph node transfer for treatment of lymphedema: a comprehensive literature review. Ann Surg. 2015;261(5):1013–23.CrossRefPubMedGoogle Scholar
  4. 4.
    Pisano M, Triacca V, Barbee KA, Swartz MA. An in vitro model of the tumor-lymphatic microenvironment with simultaneous transendothelial and luminal flows reveals mechanisms of flow enhanced invasion. Integr Biol Quant Biosci Nano Macro. 2015;7(5):525–33.Google Scholar
  5. 5.
    Saaristo A, Veikkola T, Tammela T, Enholm B, Karkkainen MJ, Pajusola K, et al. Lymphangiogenic gene therapy with minimal blood vascular side effects. J Exp Med. 2002;196(6):719–30.CrossRefPubMedPubMedCentralGoogle Scholar


  1. 6.
    Becker C, Vasile JV, Levine JL, Batista BN, Studinger RM, Chen CM, et al. Microlymphatic surgery for the treatment of iatrogenic lymphedema. Clin Plast Surg. 2012;39(4):385–98.CrossRefPubMedGoogle Scholar
  2. 7.
    Warren AG, Brorson H, Borud LJ, Slavin SA. Lymphedema: a comprehensive review. Ann Plast Surg. 2007;59(4):464–72.CrossRefPubMedGoogle Scholar
  3. 8.
    Charles R. Elephantiasis Scroti. London: Churchill; 1912.Google Scholar
  4. 9.
    Miller TA, Wyatt LE, Rudkin GH. Staged skin and subcutaneous excision for lymphedema: a favorable report of long-term results. Plast Reconstr Surg. 1998;102(5):1486–98; discussion 1499–501.Google Scholar
  5. 10.
    Brorson H. Liposuction in arm lymphedema treatment. Scand J Surg SJS Off Organ Finn Surg Soc Scand Surg Soc. 2003;92(4):287–95.Google Scholar
  6. 11.
    Frick A, Hoffmann JN, Baumeister RG, Putz R. Liposuction technique and lymphatic lesions in lower legs: anatomic study to reduce risks. Plast Reconstr Surg. 1999;103(7):1868–73; discussion 1874–5.Google Scholar
  7. 12.
    Suami H, Chang DW. Overview of surgical treatments for breast cancer-related lymphedema. Plast Reconstr Surg. 2010;126(6):1853–63.CrossRefPubMedGoogle Scholar
  8. 13.
    Campisi C, Bellini C, Campisi C, Accogli S, Bonioli E, Boccardo F. Microsurgery for lymphedema: clinical research and long-term results. Microsurgery. 2010;30(4):256–60.PubMedGoogle Scholar
  9. 14.
    Chang DW. Lymphaticovenular bypass for lymphedema management in breast cancer patients: a prospective study. Plast Reconstr Surg. 2010;126(3):752–8.CrossRefPubMedGoogle Scholar
  10. 15.
    Weiss M, Baumeister RGH, Hahn K. Post-therapeutic lymphedema: scintigraphy before and after autologous lymph vessel transplantation: 8 years of long-term follow-up. Clin Nucl Med. 2002;27(11):788–92.CrossRefPubMedGoogle Scholar
  11. 16.
    Gharb BB, Rampazzo A. Spanio di Spilimbergo S, Xu E-S, Chung K-P, Chen H-C. Vascularized lymph node transfer based on the hilar perforators improves the outcome in upper limb lymphedema. Ann Plast Surg. 2011;67(6):589–93.CrossRefPubMedGoogle Scholar
  12. 17.
    Becker C, Assouad J, Riquet M, Hidden G. Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation. Ann Surg. 2006;243(3):313–5.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 18.
    Ogata F, Narushima M, Mihara M, Azuma R, Morimoto Y, Koshima I. Intraoperative lymphography using indocyanine green dye for near-infrared fluorescence labeling in lymphedema. Ann Plast Surg. 2007;59(2):180–4.CrossRefPubMedGoogle Scholar
  14. 19.
    Teven CM, Fisher S, Ameer GA, He T-C, Reid RR. Biomimetic approaches to complex craniofacial defects. Ann Maxillofac Surg. 2015;5(1):4–13.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 20.
    Kanapathy M, Patel NM, Kalaskar DM, Mosahebi A, Mehrara BJ, Seifalian AM. Tissue-engineered lymphatic graft for the treatment of lymphedema. J Surg Res. 2014;192(2):544–54.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 21.
    Kono T, Kubo H, Shimazu C, Ueda Y, Takahashi M, Yanagi K, et al. Differentiation of lymphatic endothelial cells from embryonic stem cells on OP9 stromal cells. Arterioscler Thromb Vasc Biol. 2006;26(9):2070–6.CrossRefPubMedGoogle Scholar
  17. 22.
    Conrad C, Niess H, Huss R, Huber S, von Luettichau I, Nelson PJ, et al. Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo. Circulation. 2009;119(2):281–9.CrossRefPubMedGoogle Scholar
  18. 23.
    Mężyk-Kopeć R, Wyroba B, Stalińska K, Próchnicki T, Wiatrowska K, Kilarski WW, et al. ADAM17 Promotes Motility, Invasion, and Sprouting of Lymphatic Endothelial Cells. PLoS One. 2015;10(7):e0132661.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 24.
    Saaristo A, Veikkola T, Enholm B, Hytönen M, Arola J, Pajusola K, et al. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. FASEB J Off Publ Fed Am Soc Exp Biol. 2002;16(9):1041–9.Google Scholar
  20. 25.
    Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 2001;20(4):672–82.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 26.
    Nakamura K, Radhakrishnan K, Wong YM, Rockson SG. Anti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in mice. PLoS One. 2009;4(12):e8380.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 27.
    Choi I, Lee S, Kyoung Chung H, Suk Lee Y, Eui Kim K, Choi D, et al. 9-cis retinoic acid promotes lymphangiogenesis and enhances lymphatic vessel regeneration: therapeutic implications of 9-cis retinoic acid for secondary lymphedema. Circulation. 2012;125(7):872–82.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Section of Plastic and Reconstructive SurgeryThe University of Chicago MedicineChicagoUSA

Personalised recommendations